Mark Patrick Guerin - 13 Mar 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONTX	Stock Option (right to purchase)	Award	$0	+79,000		$0.000000	79,000	13 Mar 2023	Common Stock	79,000	$0.7300	Direct	F1
transaction	ONTX	Restricted Stock Units	Award	$0	+26,000		$0.000000	26,000	13 Mar 2023	Common Stock	26,000		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
F2	Each restricted stock unit is convertible into one share of common stock.
F3	These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary